Bupivacaine Hydrochloride recalls

10 recalls on record

Recalled by 1 agency: FDA (10).

First recall on record: October 16, 2013. Most recent: April 22, 2026.

Risk classification: Class I: 3 · Class II: 7

Recalert records 10 recalls for Bupivacaine Hydrochloride from FDA. The earliest is dated October 16, 2013 and the latest April 22, 2026. 1 recalls are dated within the last 12 months. The most frequent categories are drug. The latest recall is Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx only, Manufactured by: Houns Co., Ltd, 100, Bio valley, Je-cheor-Si, Chungcheongbuk-dc, Korea, NDC 73293-0002-1 (2 mL ampule), NDC 73293-0002-2 (50 x 2 Single-dose ampules); Distributed: Brookfield Pharmaceuticals, LLC, Brookfield, WI 53005, Made in S. Korea, NDC 71351-022-02 (ampule), NDC 71351-022-10 (10 count ampules), NDC 71351-022-50 (50 count ampules) (D-0530-2026).

Most recent recalls

Questions about this brand

Does Bupivacaine Hydrochloride have recalls in 2026?
Recalert records 1 recalls for Bupivacaine Hydrochloride dated in 2026.

Do you sell Bupivacaine Hydrochloride products? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related brands